Skip to main content
Industry News
Study: Sarilumab tied to higher A1C reduction in RA

Patients with rheumatoid arthritis who initiated treatment with sarilumab experienced higher reductions in A1C level, regardless of their diabetes status, compared with those received placebo or adalimumab. The findings in the journal Arthritis Research & Therapy were based on data from a post-hoc analysis of three phase III studies.

Full Story: